Periprocedural Anticoagulation Management of Patients With Nonvalvular Atrial Fibrillation

The 3-month cumulative incidence of TE and bleeding among patients with AF in whom anticoagulation was temporarily interrupted for an invasive procedure was low and was not significantly influenced by bridging therapy.